1 citations
,
April 2019 in “Advances in Cosmetic Surgery” Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.
1 citations
,
January 2018 in “Annals of medical research” No link found between blood groups, Rhesus factor, and ferritin levels in women with hair loss.
1 citations
,
December 2016 in “Rossijskij žurnal kožnyh i veneričeskih boleznej” A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.
1 citations
,
May 2013 in “Journal of the Egyptian Women's Dermatologic Society (Print)” PSA could be a marker for hyperandrogenism in women, but more research is needed.
June 2026 in “European Medical Journal” More severe hair loss is linked to more sexual dysfunction in both men and women.
The serum improved hair growth and comfort after hair transplant.
June 2026 in “The Sri Lanka Journal of Dermatology” Hair disorders significantly reduce quality of life.
May 2026 in “Acta Dermato Venereologica” Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.
May 2026 in “Research Square” Combining scalp cooling with a special lotion helps prevent severe hair loss in breast cancer patients undergoing chemotherapy.
May 2026 in “Indian Journal of Dermatology” Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.
May 2026 in “Dove Medical Press (Taylor and Francis Group)” Buffy coat PRP is more effective for hair growth in androgenetic alopecia than apheresis PRP.
May 2026 in “Russian Journal of Skin and Venereal Diseases” Low ferritin and vitamin D levels, past infections, stress, and weight changes can trigger hair loss in women.
May 2026 in “Frontiers in Medicine” The shampoo effectively reduces scabs after hair transplant surgery without causing discomfort.
May 2026 in “Clinical Cosmetic and Investigational Dermatology” The buffy coat method slightly outperformed apheresis in patient-reported hair improvement for treating hair loss.
May 2026 in “Journal of the Egyptian Womenʼs Dermatologic Society” Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.
Microneedling may help treat some autoimmune skin conditions, but more research is needed.
April 2026 in “Clinical and Translational Science” Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.
April 2026 in “Indian Journal of Dermatology” PRP and IT are equally effective for treating localized alopecia areata, but PRP causes more pain and bleeding.
April 2026 in “Frontiers in Immunology” Certain genes may be linked to autoimmune conditions in people with alopecia areata.
April 2026 in “Research Square” Trichoscopy is reliable for diagnosing different types of frontal non-scarring hair loss.
March 2026 in “Journal of Cosmetic Dermatology” Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.
March 2026 in “International Journal of Molecular Sciences” Grateloupia angusta extract helps heal wounds faster and improve skin repair.
March 2026 in “Preprints.org” Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.
March 2026 in “Frontiers in Medicine” High-dose testosterone with finasteride improves muscle health in males with spinal cord injury.
MITF and WNT3A are key in Dun Mongolian horse pigmentation.
March 2026 in “Trends in Sciences” A mouse model was created to study hair loss similar to humans.
March 2026 in “Molecules” Camellia sinensis seed flavonoids can reduce skin inflammation and damage from UV rays.
March 2026 in “Journal of the European Academy of Dermatology and Venereology” VESALT improves alopecia areata assessment by including non-scalp areas and is reliable and user-friendly.
March 2026 in “Journal of Investigative Dermatology” Folliculin slows hair growth, and blocking it might help treat hair loss.
March 2026 in “Journal of the American Academy of Dermatology” The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.